Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study.


Journal

American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 14 06 2018
accepted: 01 11 2018
pubmed: 9 11 2018
medline: 19 11 2019
entrez: 9 11 2018
Statut: ppublish

Résumé

Lifestyle-related factors influence risk of endometrial and ovarian cancers, but few studies have examined their joint associations with risk of these cancers. Using multivariable Cox regression models, we assessed the association of a healthy lifestyle index (HLI-a composite score (range, 0-20) involving diet, alcohol consumption, physical activity, body mass index, and smoking; higher scores represent healthier behavior) with risk of endometrial and ovarian cancers among 108,136 postmenopausal women who were recruited in the US Women's Health Initiative study between 1993 and 1998. After a median follow-up of 17.9 years, 1,435 endometrial cancer cases and 904 ovarian cancer cases had been ascertained. Women in the highest quintile of the HLI score had a lower risk of overall, type I, well-differentiated, moderately differentiated, poorly differentiated, and localized endometrial cancer than those in the lowest quintile (for quintile 5 vs. quintile 1, hazard ratio (HR) = 0.61 (95% CI: 0.51, 0.72), HR = 0.60 (95% CI: 0.49, 0.72), HR = 0.66 (95% CI: 0.46, 0.96), HR = 0.69 (95% CI: 0.52, 0.90), HR = 0.49 (95% CI: 0.34, 0.72), and HR = 0.61 (95% CI: 0.50, 0.74), respectively). The HLI score had a weak positive association with risk of serous ovarian cancer. Our findings underscore the potential importance of a healthy lifestyle in lowering endometrial cancer risk among postmenopausal women.

Identifiants

pubmed: 30407487
pii: 5165433
doi: 10.1093/aje/kwy249
pmc: PMC6357793
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

261-273

Subventions

Organisme : NHLBI NIH HHS
ID : HHSN268201600002C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600018C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600003C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600004C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201600001C
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016058
Pays : United States

Références

Ann Epidemiol. 2013 Feb;23(2):93-8
pubmed: 23273691
Br J Cancer. 2015 May 26;112(11):1816-21
pubmed: 26010500
J Clin Immunol. 2013 Jan;33 Suppl 1:S79-84
pubmed: 23225204
Endocr Relat Cancer. 2013 Mar 22;20(2):251-62
pubmed: 23404857
Eur J Cancer. 2010 Mar;46(4):690-6
pubmed: 20036529
Am J Clin Nutr. 2012 Jul;96(1):150-63
pubmed: 22592101
J Steroid Biochem Mol Biol. 2014 Jul;142:83-9
pubmed: 23680641
Asian Pac J Cancer Prev. 2014;15(21):9085-91
pubmed: 25422183
Cancer Causes Control. 2015 Nov;26(11):1691-7
pubmed: 26335264
Am J Med. 2008 Jun;121(6):501-508.e3
pubmed: 18501231
Ann Epidemiol. 2003 Oct;13(9 Suppl):S87-97
pubmed: 14575941
Cancer Prev Res (Phila). 2014 May;7(5):516-25
pubmed: 24574508
Lancet Oncol. 2012 Sep;13(9):946-56
pubmed: 22863523
Ann Epidemiol. 1999 Apr;9(3):178-87
pubmed: 10192650
Clin Obstet Gynecol. 2012 Mar;55(1):3-23
pubmed: 22343225
Ann Epidemiol. 2003 Oct;13(9 Suppl):S122-8
pubmed: 14575944
Tob Control. 2011 Jan;20(1):e2
pubmed: 21148114
Int J Cancer. 2001 Oct 1;94(1):128-34
pubmed: 11668487
Am J Prev Med. 2004 Aug;27(2 Suppl):4-17
pubmed: 15275669
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2924-35
pubmed: 25258014
Cancer Causes Control. 2013 Nov;24(11):1995-2003
pubmed: 23929278
Eur J Epidemiol. 2015 May;30(5):397-412
pubmed: 25800123
Tumour Biol. 2014 Nov;35(11):11065-73
pubmed: 25095977
Control Clin Trials. 1998 Feb;19(1):61-109
pubmed: 9492970
J Natl Cancer Inst. 2007 Oct 17;99(20):1534-43
pubmed: 17925539
Nat Rev Cancer. 2008 Mar;8(3):205-11
pubmed: 18235448
Int J Cancer. 2012 May 1;130(9):2204-10
pubmed: 21678398
Am J Prev Med. 2004 Aug;27(2 Suppl):25-33
pubmed: 15275671
Adv Exp Med Biol. 2017;943:3-46
pubmed: 27910063
BMC Cancer. 2014 Jan 10;14:12
pubmed: 24410858
Cancer Prev Res (Phila). 2014 Jan;7(1):42-53
pubmed: 24403289
PLoS One. 2016 Mar 09;11(3):e0151134
pubmed: 26960146
JAMA. 2003 Sep 10;290(10):1331-6
pubmed: 12966124
Nat Rev Endocrinol. 2014 Aug;10(8):455-465
pubmed: 24935119
BMC Cancer. 2017 Nov 13;17(1):757
pubmed: 29132343
Cancer Causes Control. 2014 Apr;25(4):479-89
pubmed: 24487725
Recent Results Cancer Res. 2016;208:155-176
pubmed: 27909907
Medicine (Baltimore). 2016 Apr;95(16):e2850
pubmed: 27100409
Am J Epidemiol. 1984 Jan;119(1):9-22
pubmed: 6362403
Horm Metab Res. 2003 Nov-Dec;35(11-12):694-704
pubmed: 14710348
Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):275-85
pubmed: 23292084
Arch Gynecol Obstet. 2017 Feb;295(2):467-479
pubmed: 27975130
Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):255-73
pubmed: 24142805
Gynecol Oncol. 2011 May 1;121(2):376-82
pubmed: 21324514
Am J Clin Nutr. 2015 Mar;101(3):558-69
pubmed: 25733641
Obstet Gynecol. 2003 Jun;101(6):1221-8
pubmed: 12798528
Am J Epidemiol. 1986 Jul;124(1):17-27
pubmed: 3521261

Auteurs

Rhonda Arthur (R)

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.

Theodore M Brasky (TM)

Division of Cancer Prevention and Control, Department of Internal Medicine, Ohio State University College of Medicine, Columbus, Ohio.

Tracy E Crane (TE)

College of Nursing, University of Arizona, Tucson, Arizona.

Ashley S Felix (AS)

Division of Epidemiology, College of Public Health, Ohio State University, Columbus, Ohio.

Andrew M Kaunitz (AM)

Department of Obstetrics and Gynecology, University of Florida, Jacksonville, Florida.

Aladdin H Shadyab (AH)

Department of Family Medicine and Public Health, School of Medicine, University of California, San Diego, La Jolla, California.

Lihong Qi (L)

Division of Biostatistics, Department of Public Health Sciences, University of California, Davis, Davis, California.

Sylvia Wassertheil-Smoller (S)

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.

Thomas E Rohan (TE)

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH